Max Narovlyansky

Founder & CEO at FlowCell

Max’s early research focused on microfluidic technologies addressing the fact that pre-analytics is the limiting factor in biological research and medical treatment. Specifically, electrokinetic manipulation of cells and protein is a novel but highly efficient tool. He has shown it to be applicable to capture and lysis of cells and extremely rapid resolution of proteins. One of his contributions described using the similitude condition between electric field and flow of charged species, which allowed precise shaping of molecular distribution for enhanced diagnostic separation. Other work has focused on the sensors, including the incorporation of optical and electrochemical elements in traditional and paper-based microfluidics. Other microfluidic applications have involved creative use of reactive flows, including in situ reduction reactions for micropatterning of films.

Org chart

Timeline

  • Founder & CEO

    Current role

View in org chart